Endurant Capital Management LP - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 182 filers reported holding PTC THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.

Quarter-by-quarter ownership
Endurant Capital Management LP ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,579,285
+277.8%
53,247
+197.7%
1.32%
+378.3%
Q4 2022$682,709
-31.6%
17,886
-9.1%
0.28%
+403.6%
Q2 2020$998,000
+56.9%
19,677
+16.4%
0.06%
-78.1%
Q1 2019$636,000
+32.5%
16,903
+14.2%
0.25%
+55.9%
Q4 2015$480,000
-21.8%
14,800
-35.7%
0.16%
-21.5%
Q3 2015$614,000
-47.1%
23,000
-4.6%
0.20%
-40.1%
Q2 2015$1,160,00024,1000.34%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,750,000$84,053,0007.32%
RTW INVESTMENTS, LP 3,832,480$184,074,0006.94%
Burrage Capital Management LLC 195,725$9,401,0006.30%
Asymmetry Capital Management, L.P. 55,408$2,661,0004.77%
SECTORAL ASSET MANAGEMENT INC 328,738$15,789,0002.36%
ARMISTICE CAPITAL, LLC 758,000$36,407,0002.10%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 114,000$5,470,0001.97%
Opaleye Management Inc. 191,000$9,174,0001.80%
Sofinnova Investments, Inc. 517,092$24,836,0001.79%
Chubb Ltd 8,180$393,0001.68%
View complete list of PTC THERAPEUTICS INC shareholders